FDA Inspection
Eurofins Lancaster Laboratories, IncEurofins Lancaster Laboratories, Inc – FDA Inspection, Sep 7, 2010
Record Details
This FDA Inspection record concerns Eurofins Lancaster Laboratories, Inc, with an inspection on September 7, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- September 7, 2010
- Product Type
- Drugs
View Company Profile
ID · 5bdfe535-9f2c-495f-b019-2ad3fcce8421
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 681727
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.160(b)(4)Calibration - at intervals, written program, remedial action
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Eurofins Lancaster Laboratories, Inc
13| Date | Classification | Office | Project area |
|---|---|---|---|
| September 23, 2025 | Not classified | Philadelphia District Office | |
| August 26, 2025 | VAI | Philadelphia District Office | Drug Quality Assurance |
| October 21, 2021 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| October 17, 2019 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| September 13, 2019 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Eurofins Lancaster Laboratories, Inc
- FDA Inspection 1284580 - 2025-09-23
- FDA Inspection 1279557 - 2025-08-26
- FDA Inspection 1156933 - 2021-10-21
- FDA Inspection 1113269 - 2019-10-17
- FDA Inspection 1106449 - 2019-09-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.